Workflow
眼视光
icon
Search documents
睿视科技再获数千万元新一轮融资,加速“AI+视觉神经干预”创新与应用
IPO早知道· 2025-08-13 08:50
Core Viewpoint - The article discusses the recent financing round of Ruisi Technology, highlighting its innovative approach to myopia prevention through AI and visual neural intervention, and the establishment of a comprehensive "product-data-service" closed-loop system [2][4]. Financing and Investment - Ruisi Technology recently completed a multi-million financing round led by Huaxi Jinzhi, with existing shareholder Innovation Works increasing their investment [2]. - The funds will be allocated for clinical registration, sales enhancement, brand building, and ongoing product R&D [2]. Technology and Product Development - The company focuses on addressing the core issues of myopia prevention in adolescents, leveraging advanced AI technology and clinical evidence [2]. - Ruisi Technology is developing a "light-eye-brain" intelligent treatment closed-loop system, integrating optical stimulation, neural regulation, and AI feedback [2][3]. - The product system is characterized by "strong technology + soft standards," with innovations in hardware and algorithmic layers [2]. Clinical Validation and Efficacy - Clinical studies involving reputable medical institutions show that Ruisi Technology's products significantly outperform traditional myopia prevention methods [3]. - In a real-world study of nearly 200 cases over six months, the experimental group showed an average axial length increase of only 0.038mm, compared to 0.125mm in the control group [3]. Market Position and Future Outlook - Ruisi Technology aims to integrate treatment into daily life, promoting a seamless experience of "learning while treating" and "playing while adjusting" [3]. - The company has established a network of hundreds of professional institutions and over 1,000 stores, laying the groundwork for a long-term prescription treatment model [3]. - The co-founder expressed confidence in the company's unique advantages in original technology, real-world validation, and industry standards, projecting over 100% revenue growth year-on-year for the first half of 2025 [4]. Industry Insights - The eye care sector is recognized as a vast and mature market, with significant potential for growth driven by technological advancements [5]. - Investors have noted Ruisi Technology's differentiated products supported by clinical data, which naturally integrate into learning and entertainment scenarios, creating high industry barriers [5]. - The company's innovative "Far Vision Light Screen" product has gained recognition among eye care professionals and users, enhancing personalized myopia management services [5].
聚焦智能眼镜业务,雷神科技与欧普康视、汇鼎光学签约成立合资公司
Cai Fu Zai Xian· 2025-07-07 06:29
Group 1 - Raytheon Technology announced a joint investment with Jiangsu Huiding Optical Glasses Co., Ltd. and Optecon Vision Investment Co., Ltd. to establish Jiangsu Rayou Huiding Smart Glasses Co., Ltd., with Raytheon holding a 35% stake [1] - The establishment of the joint venture is expected to enhance the market expansion and strategic layout of Raytheon's smart glasses business [1] Group 2 - Raytheon Technology is recognized as the "first stock in e-sports equipment" on the Beijing Stock Exchange and has been listed in the "China's 500 Most Valuable Brands" for five consecutive years, with a brand value of 21.839 billion [3] - The Raytheon AI Magic Mirror (Raytheon Aura AI Smart Shooting Glasses) was officially launched on June 17, featuring a 1.2 million pixel camera, Sony IMX681 sensor, and Qualcomm Snapdragon AR1 chip, weighing only 39g [3] - Huiding Optical is one of the top three optical brands in China by lens sales, with a service network covering over 2,100 clients nationwide [3] - Optecon Vision is the first listed high-tech enterprise in the eye care sector in China, collaborating with over 1,500 well-known medical institutions and covering more than 2,000 professional optical channel partners [3] Group 3 - The partnership aims to leverage Huiding Optical and Optecon Vision's nationwide sales channels and user resources to accelerate the penetration of Raytheon AI Magic Mirror into offline channels [4] - The collaboration will also provide professional support for the development and upgrade of Raytheon's smart glasses through their teams specializing in myopia prevention and eye health management [4] - This initiative is part of Raytheon Technology's strategy to create a closed-loop ecosystem encompassing product development, channel access, and terminal services [4] Group 4 - According to the National Health Commission, the number of myopia patients in China has exceeded 700 million, with offline optical stores being the primary sales channel for glasses [6] - Euromonitor International indicates that offline optical stores will account for 81.8% of the eyewear sales channels in China by 2024, making them a crucial channel for promoting AI/AR glasses [6] - Raytheon Technology aims to transform into a diversified multi-channel layout, seizing the initiative in the industry chain layout [6] - The company is committed to providing an exceptional user experience and plans to collaborate with more ecosystem partners in product development, market expansion, and service ecosystem construction [6]
瞳朋MRT新品发布会圆满落幕,共绘近视防控新蓝图
Jin Tou Wang· 2025-05-22 02:17
科技领航,共探近视防控新路径 发布会伊始,屈光地形图MRT技术开创者、中国医疗装备协会入库专家、北京尼莫眼科技术研究院院 长冬雪川博士率先登台,带来了一场精彩的技术解读。他深入剖析了MRT技术如何凭借精准的数据采 集与定制化方案,为近视防控领域带来突破性进展。冬雪川博士指出:"传统视力筛查存在诸多局限, 而MRT技术不仅填补了这一空白,更通过动态监测与离焦调控,为青少年近视管理提供了科学、有效 的路径。"这一观点引发了与会者的广泛关注与深入思考。 随后,温州医科大学眼视光科研副主任刘新婷教授发表了《MRT离焦技术在全球近视防控中的前沿应 用》的主题演讲。她结合丰富的临床案例,着重强调了近视防控需多方联动的理念,指出技术只有与教 育、家庭及社会紧密结合,才能构建起系统性的防控网络,为近视防控工作提供了全面且深入的思路。 北京盛达视光科技有限公司全国培训总监王硕则从市场角度出发,详细解析了MRT技术如何赋能终端 服务。他提到,该技术有助于推动行业标准化与专业化升级,为眼视光行业的发展注入了新的活力。 通讯员 阎军 2025年5月20日下午,湖南长沙迎来了一场眼视光领域的盛会——瞳朋MRT新品发布会。 此次发布会由 ...
近千万元!数字视光创新企业完成天使轮
思宇MedTech· 2025-03-17 03:55
产品与技术 火眼睛晶的核心产品是 青少年儿童VR智能视训仪M1 ,该产品由火眼睛晶与中山大学中山眼科中心联合研 发。该设备采用全球领先的Pancake短焦光学技术, 整机重量仅160克,佩戴轻便舒适 ,并通过国家级视觉 健康安全标准和TUV防蓝光认证。 合作伙伴征集:2025全球手术机器人大会 报名:首届全球眼科大会 | 暂定议程 报名:首届全球心血管大会 | 奖项报名倒计时 报名:首届全球骨科大会 | 奖项报名倒计时 近日, 深圳市火眼睛晶医疗科技有限公司 (以下简称"火眼睛晶")宣布 完成 近千万元 天使轮融资 ,本次 融资由时代伯乐独家投资。资金将主要用于加速公司在眼视光XR智能医疗领域的研发迭代与市场拓展,推动 儿童青少年近视防控技术迈向智能化新阶段。 # 关于火眼睛晶 深圳市火眼睛晶医疗科技有限公司是一家专注于数字视光领域的创新型企业, 致力于通过 XR(扩展现实) +AI技术 为眼健康问题提供智能化解决方案 。公司成立于2022年,总部位于深圳,由前华为高层创立。火眼 睛晶以解决医疗资源不平衡为使命,通过技术创新推动眼视光领域的智能化发展。 在技术层面,火眼睛晶融合了 "周边离焦理论"与"无极变焦 ...